This website uses cookies

We use cookies and website tracking tools to provide you with the best online experience. Learn more in our /en/news/hih-news/privacy-notice/privacy statement.

if you accept, your choice will be valid until cancellation.

If you disallow cookies, functionality of our website might be limited.

 

  • Als vor etwas über 20 Jahren die Standortentscheidung der Gemein­nützigen Hertie-Stiftung fiel, war dies ein außerordentlicher Glücksfall für die Universität Tübingen. Mit dem Hertie-Institut für klinische Hirnforschung haben wir eine beispielhafte Einrichtung von höchstem Renommee vor Ort, die maßgeblich dazu beitrug, Tübingen international als eine Top-Adresse für Hirnforschung bekannt zu machen.

    Prof. Dr. Bernd Engler
    Rektor Universität Tübingen
    Bild: U. Metz/Universität Tübingen
  • Das Hertie-Institut für klinische Hirnforschung steht für die Exzellenz des Wissenschaftsstandortes Tübingen. Nur gemeinsam konnten Universität und Institute im nationalen Wettbewerb auf Spitzenplätze vorstoßen. Auch städtebaulich ist das Institut eine Zierde. Grund also stolz und dankbar zu sein angesichts der Leistungen der ersten 20 Jahre. Ad multos annos!

    Boris Palmer
    Oberbürgermeister Tübingen
    Bild: Manfred Grohe
  • Das Hertie-Institut für klinische Hirnforschung ist die wichtigste Initiative innerhalb unseres Bereiches Gehirn erforschen. Ich gratuliere im Namen der Stiftung zu 20 Jahren Spitzenforschung.

    Dr. Frank-Jürgen Weise
    Vorstandsvorsitzender der Gemeinnützigen Hertie-Stiftung
    Bild: Hertie-Stiftung/Marck Krause
  • Das Zentrum für Neurologie ist Vorreiter für eine erfolgreich gelebte Translation in der Neuromedizin und hat damit eine hohe Vorbildfunktion für die Bundesrepublik. Das hat der Wissenschaftsrat in seiner Stellungnahme 2015 gewürdigt.

    Prof. Dr. Hans-Jochen Heinze
    HIH-Kuratoriumsvorsitzender
    Bild: Melitta Schubert/Universitätsmedizin Magdeburg
  • Klinisch innovative Forschung, bereichernde translationale und interdisziplinäre Zusammenarbeit und gelebte Weltoffenheit in einer für eine Familie äußerst lebenswerten schwäbischen Kleinstadt – ich habe sehr positive Erinnerungen an meine Zeit am HIH. Das HIH bietet besonders umfassende Möglichkeiten einer ärztlich-wissenschaftlichen Berufung nachzugehen und den persönlichen Weg zu finden.

    Prof. Dr. Daniela Berg
    Direktorin der Klinik für Neurologie, Kiel
    Bild: UKSH
  • Das HIH bietet ein exzellentes Umfeld und eine erstklassige Infrastruktur, um erfolgreich molekulare Mechanismen neurodegenerativer Erkrankungen zu erforschen. Die gelebte interdisziplinäre Zusammenarbeit mit den Kolleginnen und Kollegen, welche ich von der ersten Stunde an erleben durfte, haben den Grundstein für meine Laufbahn in der translationalen Biomedizin gelegt. Herzlichen Glückwunsch zum Jubiläum!

    Prof. Dr. Rejko Krüger
    Director of Transversal Translational Medicine, Luxembourg Institute of Health
    Bild: Olivimages
  • Das HIH ist für mich ein einzigartiger Ort für Spitzenforschung – und hat mir zudem gezeigt, wie wichtig es ist, interdisziplinär zu denken und seine Erkenntnisse auf packende Art mit der Welt zu teilen.

    Dr. Henning Beck
    Neurowissenschaftler, Science Slammer & Wissenschaftsautor
    Bild: Privat
  • Meine Begeisterung zur Mathematik wurde in meiner Zeit als Doktorandin am Hertie-Institut zur Leidenschaft, komplexe neurologische Prozesse zu verstehen. Dies wurde mir, wie auch so vielen anderen Nachwuchswissenschaftler*innen, unter anderem auch durch die Unterstützung und exzellente Infrastruktur des Instituts ermöglicht. Ich gratuliere herzlich zum 20jährigen Jubiläum!

    Dr. Daniela Vallentin
    Forschungsgruppenleiterin, MPI für Ornithologie
    Bild: Privat
  • Einen Zustand kann man ändern – Durch langjährige und sehr umfangreiche Hirnforschung am HIH und dem Zentrum für Neurologie wurde eine spezielle Therapiemethode entwickelt, welche mir nach meinem Schlaganfall geholfen hat, wieder den Weg zurück ins ‚normale‘ Leben zu finden. Beruflich integriert – gesellschaftlich etabliert.

    Sandra Friesch
    Ehemalige Patientin
    Bild: Verena Müller / UKT
  • Ich gratuliere dem Hertie-Institut zum 20-jährigen Bestehen auf das Herzlichste! Die exzellenten Leistungen des Instituts kommen Patientinnen und Patienten unmittelbar zugute, und deshalb unterstützen wir von Seiten des Landes Baden-Württemberg die Arbeit des Instituts aus Überzeugung. Das Institut leistet wertvolle Beiträge für die Medizinforschung im Land und ich bin gespannt auf die Resultate in Forschung und Translation, die wir in den kommenden Jahren vom Hertie Institut erwarten dürfen.

    Theresia Bauer
    MdL, Ministerin für Wissenschaft, Forschung und Kunst Baden-Württemberg
    Bild: Sabine Arndt
  • Mit der Errichtung des Hertie-Instituts für klinische Hirnforschung wurde vor 20 Jahren der Grundstein für den Tübinger Neurocampus gelegt. Das war ein wichtiger erster Schritt für die heute hervorragende neurologische Grundlagenforschung, translationale Forschung und klinische Anwendung. Durch die Verzahnung von Forschung und Krankenversorgung ist das HIH am Standort Tübingen ein entscheidender Mehrwert für unsere neurologischen Patientinnen und Patienten. Herzlichen Glückwunsch zu 20 Jahren HIH!

    Prof. Dr. Michael Bamberg
    Leitender Ärztlicher Direktor Universitätsklinikum Tübingen
    Bild: Verena Müller / UKT
  • Die enge Zusammenarbeit von Grundlagenwissenschaftlern und Klinikern auf dem Tübinger Neurocampus ermöglicht eine rasche Umsetzung neuer Diagnose- und Therapieverfahren in die Praxis – dank dieses Erfolgsmodells konnte sich der Standort Tübingen zu einem Leuchtturm der Neurologischen Forschung entwickeln. Die Medizinische Fakultät gratuliert dem HIH zum 20-jährigen Bestehen und freut sich auf die weitere Zusammenarbeit.

    Prof. Dr. Bernd Pichler
    Dekan Medizinische Fakultät Tübingen
    Bild: Universität Tübingen

Laying the foundations for tomorrow's medicine

News

  • Why red wine might play a role in a future ALS therapy

    A team led by Prof. Philipp Kahle discovers a basic disease mechanism of amyotrophic lateral sclerosis (ALS). Their finding: a red wine substance regulates an important enzyme and could be a therapeutic approach.

    Read our press release

  • Call for Applications: Johannes Dichgans Doctoral Scholarship

    At the Hertie Institute for Clinical Brain Research, as part of the Johannes Dichgans scholarship program, doctoral scholarships for students of human medicine will again be offered for the winter semester 2022/23.

    More information

  • Two million euros annually for brain research

    The Hertie Institute for Clinical Brain Research will receive permanent funding from the State of Baden-Württemberg in the future. The institute celebrated its 20th anniversary on Wednesday, May 4, 2022 with aceremony attended by Science Minister Theresia Bauer.

    See our press release for further information (in German only)

  • Fighting stroke with oxygen and a cool head

    May 10 marks Tag gegen den Schlaganfall in Germany. In an interview with the Hertie Foundation on this occasion, Dr. Sven Poli explains high-dose oxygen therapy, which is intended to prevent long-term brain damage in stroke patients also discusses the role of artificial intelligence.

    Read the interview (in German only)

  • HIH congratulates the Tübingen Tumor Center on its new director

    Since April, the Tumor Center CCC Tübingen-Stuttgart has been headed by Prof. Sara Brucker (Department of Women's Health Tübingen). Prof. Ghazaleh Tabatabai became deputy spokesperson of the clinical area. With this position, the HIH Director continues to build bridges between neurosciences and oncology in Tübingen.

    Press release (in German only)

Departments

  • Neurology and Stroke

    The Department of Neurology and Stroke has the main focuses in neurovascular medicine (vessel diseases of the brain, cerebral stroke), neuro-oncology (brain tumors, brain metastases), neuro-immunology (e.g., multiple sclerosis) and neuro-intensive medicine. ...more information

  • Neurodegenerative Diseases

    The Department of Neurodegenerative Diseases treats in-patients on a ward of about 20 beds and in several out-patient clinics. The clinical focus lies on neurodegenerative diseases such as Parkinson’s disease, the ataxias, spastic paraplegias, and dementias. ...more information

  • Neurology and Epileptology

    The Department of Neurology and Epileptology has a focus on epilepsy and other paroxysmal neurological disorders. In these diseases, the excitability of nerve cells temporarily changes either due to genetic or acquired defects. ...more information

  • Department of Neurology and Interdisciplinary Neuro-Oncology

    The Department of Neurology and Interdisciplinary Neuro-Oncology became the HIH's sixth department in 2020 with Prof. Dr. Dr. Ghazaleh Tabatabai as the first woman among the directors ...more information

  • Neural Dynamics and Magnetoencephalography

    The Department of Neural Dynamics and Magnetoencephalography was founded in the year 2020 and Prof. Dr. Markus Siegel was appointed head of the department. ...more information

  • Cellular Neurology

    Our research focus is on the cellular and molecular mechanisms of brain aging and age-related neurodegenerative diseases, with a special emphasis on the pathogenesis of Alzheimer´s disease and other cerebral proteopathies ...more information

  • Independent Research Groups

    The independent research groups at the HIH focus on a variety of research topics ...more information

Research groups

  • Neurology and Stroke

    Brain Networks and Plasticity

    The human brain possesses the remarkable capacity of reorganization, which is the basis for adapting to constantly changing environmental conditions. This plasticity is of paramount importance ...more information

  • Independent Research Group

    Neuropsychology of Action

    The Research Group "Neuropsychology of Action" is dedicated to investigations of human action control. We study clinical impairments of action control and their neural substrates in patients with brain damage ...more information

  • Cellular Neurology

    Experimental Neuroimmunology

    An immune response is part of most neurological diseases, and the development of late-onset Alzheimer's Disease (AD) has been linked to immune related genes and most recently also to epigenetic modifications. ...more information

  • Neurodegenerative Diseases

    Genetics of Parkinson's disease

    Parkinson's syndrome (PS) is the second most common neurodegenerative disease after Alzheimer's dementia. The vast majority of patients are ill with no apparent cause. ...more information

  • Cellular Neurology

    Dementia Research Unit

    The Dementia Research Unit is a clinical research unit of the Department of Cellular Neurology and the Department of Psychiatry. It closely collaborates with the outpatient Memory Clinic. ...more information

  • Neurology and Epileptology

    Clinical Genetics of Paroxysmal Neurological Diseases

    Paroxysmal neurological disorders include a broad spectrum of clinical entities such as migraine, episodic ataxia or myotonia. The research group is focussed on the clinical genetics ...more information

  • Independent Research Group

    Oculomotor Laboratory

    Playing video-games is a widely distributed leisure activity in our society. In order to estimate the consequences of video-game play, we study the details of eye movements and pupil light responses ... more information

  • Cellular Neurology

    Experimental Neuropathology

    Cerebral proteopathy is a unifying term for cerebral neurodegenerative diseases in which aggregated proteins are abnormally deposited in the brain. The hallmark proteopathy is Alzheimer's disease (AD) ...more information

  • Independent Research Group

    Molecular Brain Development

    The mammalian neocortex is a highly complex and spatially heterogeneous structure, which has expanded significantly in mammalian evolution. Neocortical network function is at the heart of cognitive function ...more info

  • Neurology and Stroke

    Neurological B cell Immunology

    The research group “Neurological B cell Immunology” is focused on the role of B cells in neuro-inflammatory diseases including multiple sclerosis (MS) and... more information

  • Neural Dynamics and Magnetoencephalography

    Neural Dynamics and Magnetoencephalography

    The central goal of the laboratory is to investigate how cognition and behavior emerges from dynamic interactions across widely distributed neuronal ensembles... more information

  • Independent Research Group

    Human Intracranial Cognitive Neurophysiology

    The goal of the Helfrich lab is to unravel the neural network mechanisms supporting higher cognitive functions  ...more info

  • Neurology and Epileptology

    Experimental Neurophysiology of Channelopathies

    Our research group uses transgenic mouse models to investigate the molecular mechanisms of disease-associated variants in genes encoding neuronal ion channels. ...more information

Research groups

  • Neurodegenerative Diseases

    Clinical Parkinson's Disease Research

    Parkinson's disease (PD) is the second most frequent neurodegenerative disorder after Alzheimer’s disease and affects about 1 to 2 % of individuals over the age of 65. The number is steadily increasing due to demographic changes in Western countries. ...more information

  • Cellular Neurology

    Glia Biology Unit

    Glial cells are highly abundant in the mammalian brain, yet many questions regarding their development, function, and involvement in disease remain unanswered. ...more information

  • Neurology and Stroke

    Molecular Neurooncology

    Three to five of 100.000 people are annually diagnosed with a glioblastoma (GBM), the most malignant brain tumor in adults. Despite aggressive multimodal treatment including surgical resection and ...more information

  •  Unit

    Cellular Neurology

    Molecular Biomarkers Unit

    Processes related to Alzheimer ́s disease (AD) and other age-related neurodegenerative diseases start many years before the onset of the first clinical symptoms. At the moment of the first clinical complaints, the disease has already caused ...more information

  • Neurology and Epileptology

    Translational Imaging

    The focus of our research group is the structural and functional imaging of neurological diseases with a particular focus on epileptology. We use multi-modal imaging techniques to improve the understanding of disease development ...more information

  • Neurodegenerative Diseases

    Dystonia

    Dystonia is the third most common movement disorder, and mutations in a growing number of genes have been identified as causes for hereditary forms in many cases. The aim of the group, which brings together clinical experience ...more information

  • Neurology and Stroke

    Stroke and Neuroprotection

    The research focus of our Stroke and Neuroprotection Laboratory is to find new and to optimize existing neuroprotective strategies ...more information

  • Neurology and Epileptology

    Experimental Epileptology

    Our research group is interested to unravel the mechanisms of well defined, mainly genetic, neurological, paroxysmal diseases, to understand correlations with clinical symptoms and to find new treatment options. ...more information

  • Independent Research Group

    Active Perception Lab

    Humans are tremendously reliant on the sense of vision to interact with their environment. Such interaction often involves the generation of motor outputs ...more information

  • Neurodegenerative Diseases

    Mitochondrial Biology of Parkinson’s Disease

    Neurodegenerative disorders are associated in a proportion of cases with genetic risk and gene mutations. However, the vast majority …more info

  • Neurology and Epileptology

    Neuromuscular Imaging Group

    The group works on different projects concerning nerve imaging, particularly high-resolution ultrasound in neuromuscular disorders ...more information

  • Neuro-Oncology

    Laboratory for Clinical and Experimental Neuro-Oncology

    The Interdisciplinary Division of Neuro-Oncology at the Hertie-Institut for Clinical Brain Research is the result of the, in the context of the Excellent Initiative, newly created W3-Professorship in Neuro-Oncology ... more information

Research groups

  • Neurology and Epileptology

    Migraines and Primary Headache Disorders

    Our group aims at unraveling the molecular pathophysiology of migraine and other primary headache disorders. ...more information

  • Neurodegenerative Diseases

    Section for Clinical Neurogenetics

    Neurogenetic diseases like cerebellar ataxia, hereditary spastic paraplegia and leukodystrophy are rare disorders. ...more information

  • Independent Research Group

    Cognitive Neurology

    The lab addresses a variety of topics that, at first glance, may look disparate. Yet, there is a common denominator ...more information

  • Neurodegenerative Diseases

    Genomic of Rare Movement Disorders

    Our group specializes in rare diseases. A disease is called rare, when it affects no more than 5 of 100,000 people. However, in the grand-scheme of things, rare diseases are not quite so rare ...more information

  • Independent Research Group

    Section for Computational Sensomotorics

    The Section for Computational Sensomotorics investigates theoretical principles in the perception and control of motor actions. Research is organized around three main topics ...more information

  • Independent Research Group

    Section for Neuropsychology

    The Section for Neuropsychology focuses on the investigation of spatial cognition and object recognition in humans. The current issues of our work comprise the action control and sensorimotor coordination ...more information

  • Neurodegenerative Diseases

    Functional Neurogenetics

    Age-related neurodegenerative diseases are a severe and increasingly worrisome burden for our aging population. Most of the chronic neurodegenerative diseases ...more information

  • Independent Research Group

    Systems Neurophysiology Lab

    The overarching goal of our work is to understand the operating principles of the neocortex, a unique brain structure, which mainly evolved in mammals. There is clear evidence that the neocortex, in the broadest sense, endows the subject with cognitive capabilities. ...more information

  • Neurodegenerative Diseases

    Deep Brain Stimulation

    The working group aims to uncover mechanisms of action of deep brain stimulation therapy and to translate the pathophysiological insights into future developments. …more information

  • Independent Research Group

    Motor Control Modeling

    The research group „Multi-Level Modeling in Motor Control and Rehabilitation Robotics“ focuses on the generation and control of active biological movements. We develop ...more information

  • Neuro-Oncology

    Experimental Pediatric Neuro-Oncology

    Brain tumors are the leading cause of cancer-related deaths in infants, children, and adolescents. Our lab is mostly focusing on embryonal brain tumors including ... more information

  • Independent Research Group

    Neuron-Glia Interactions

    The goal of the Snaidero lab is to decipher and control cellular interactions between neurons and glia cells in the cortex, focussing on the dynamic processes underlying myelination. ... more information

  • Neuro-Oncology

    Health Care Research in Neuro-Oncology

    The group focuses on the health-related quality of life, psychosocial burden and unmet needs in neuro-oncological patients. Our key question is... more information

No news available.

Combining excellent research and patient care

Click on the image to watch the video